Legacy Biologics and a Technical Lifecycle Plan

In today's featured interview from BioProcess International 2013, Naveen Pathak, Associate Director, Technical Strategy, Manufacturing Science & Technology, Genzyme talks about developing a manufacturing strategy and life cycle plans that should be developed for legacy biologics. This plan takes all process improvement opportunities and links it to a product and business strategy.  What does this do for your process?  Watch the interview to find out:



At this year's 2014 BioProcess International Event, we feature the full day symposium Knowledge Management across the Product and Process Lifecycle.  During this program, we'll hear from companies including Roche Diagnostics, Genzyme Corporation,  Genentech and more about knowledge management, continuous process improvement and more.  To find out more about these sessions, download the agenda.  If you'd like to join us this October 20-23, 2014 in Boston to see these sessions, as a reader of this blog, when you register to join us and mention code BPI14BLOG to save 15% off the standard rate.

Share this article with your social network, just click below to share now!

Share |